IN2013MU02101A - - Google Patents

Info

Publication number
IN2013MU02101A
IN2013MU02101A IN2101MU2013A IN2013MU02101A IN 2013MU02101 A IN2013MU02101 A IN 2013MU02101A IN 2101MU2013 A IN2101MU2013 A IN 2101MU2013A IN 2013MU02101 A IN2013MU02101 A IN 2013MU02101A
Authority
IN
India
Prior art keywords
tamsulosin
compositions
salts
core
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Jain Girish
Sudhakar Dabre Rahul
Inderjeetsingh Huda
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to US14/767,625 priority Critical patent/US20160074333A1/en
Priority to KR1020157032734A priority patent/KR20160021095A/ko
Priority to RU2015143891A priority patent/RU2015143891A/ru
Priority to PCT/IB2014/062232 priority patent/WO2014203137A2/en
Priority to IN2101MU2013 priority patent/IN2013MU02101A/en
Priority to CN201480017958.XA priority patent/CN105073100A/zh
Priority to BR112015024348A priority patent/BR112015024348A2/pt
Publication of IN2013MU02101A publication Critical patent/IN2013MU02101A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2101MU2013 2013-06-21 2014-06-14 IN2013MU02101A (enExample)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US14/767,625 US20160074333A1 (en) 2013-06-21 2014-06-14 Pharmaceutical compositions of tamsulosin or salts thereof
KR1020157032734A KR20160021095A (ko) 2013-06-21 2014-06-14 탐술로신 또는 이의 염의 약학 조성물
RU2015143891A RU2015143891A (ru) 2013-06-21 2014-06-14 Фармацевтические составы тамсулозина или его солей
PCT/IB2014/062232 WO2014203137A2 (en) 2013-06-21 2014-06-14 Pharmaceutical compositions of tamsulosin or salts thereof
IN2101MU2013 IN2013MU02101A (enExample) 2013-06-21 2014-06-14
CN201480017958.XA CN105073100A (zh) 2013-06-21 2014-06-14 坦索罗辛或其盐的药物组合物
BR112015024348A BR112015024348A2 (pt) 2013-06-21 2014-06-14 composições farmacêuticas de tansulosina ou sais destas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2101MU2013 IN2013MU02101A (enExample) 2013-06-21 2014-06-14

Publications (1)

Publication Number Publication Date
IN2013MU02101A true IN2013MU02101A (enExample) 2015-06-05

Family

ID=54396389

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2101MU2013 IN2013MU02101A (enExample) 2013-06-21 2014-06-14

Country Status (1)

Country Link
IN (1) IN2013MU02101A (enExample)

Similar Documents

Publication Publication Date Title
IL283760A (en) Preparations containing dextromethorphan and bupropion or similar substances and their uses
HUE039931T2 (hu) Szfingozin-1-foszfát receptor agonisták, azok elkészítési eljárásai, és azokat aktív ágensként tartalmazó gyógyszerészeti készítmények
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
WO2014203137A3 (en) Pharmaceutical compositions of tamsulosin or salts thereof
MX2016014320A (es) Composiciones de suspension de liberacion prolongada.
PH12016500170A1 (en) Formulation of syk inhibitors
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
EP2964693A4 (en) STABLE STABLE COMPOUNDS OF 1,1,1,4,4,4-HEXAFLUOR-2-BUTENE
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
MX2015012414A (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
EP3206706A4 (en) Stable injectable composition of pharmaceutically active agents and process for its preparation
HK1214618A1 (zh) 含有透明質酸的穩定化組合物
MX2016007315A (es) Formulaciones de bifentrina preparadas como fertilizante liquido.
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
WO2016001905A3 (en) Stable liquid ready-to-use injectable formulation of bortezomib
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12016501814A1 (en) Inhibitors of the wnt signalling pathways
WO2014166836A8 (en) Growth hormone compound formulation
WO2014186344A3 (en) Methods and agents for treating tyrosinase-positive albinism
CA2896792C (en) Stabilized cyazofamid composition
IN2013MU02101A (enExample)
IN2013MU02100A (enExample)
IN2014MU00284A (enExample)